Chipiron
Making MRIs as common and simple as blood sampling, allowing prevention and medical imaging availability at scale.
MRI is medicine’s best imaging technique, producing 3D images with incredible details. Contrary to alternatives, it is non-ionizing, which makes it comparatively harmless. However, MRIs are difficult to obtain; MRIs are inaccessible to 75% of the world’s population. For those with access, the waiting time can be about 34 days on average, and use of MRIs is restricted to the most urgent cases.
Chipiron develops a new detection system based on quantum detectors called SQUID. This is a cutting-edge low-noise amplification system, highly engineered magnetic shielding, and new low-field rapid sequences to reach sensitivity thresholds that have never been reached. This means that magnetic intensity is not the first driver of image quality, and current SNR can be obtained under 10mT. By doing so, a new generation of MRI devices that are no longer heavy, expensive, or cumbersome will emerge.
Founders
Evan Kervella
CEO
Evan holds a Master of Engineering from École Centrale. He started his first company at 21, then Chipiron at 25. He has built an extensive network in the medical world over the years, from which the idea of Chipiron emerged. Evan was awarded the Forbes 30 Under 30 title in 2022.
Dimitri Labat
CTO
Dimitri holds a Ph.D. in theoretical physics and a physics degree from the École Normal Supérieure. He had one of the highest rankings in France at the prestigious Agrégation competitive exam. Dimitri is an expert on superconductivity, which is at the core of Chipiron’s solution. Dimitri was awarded the MIT TR 35 in 2022.
Milestones
Founded at Entrepreneur First
Seed ($2.5 million) led by Demeter & Hoxton Ventures